A randomized, double-blind, placebo-controlled study of monoclonal Anti-IgE antibody Omalizumab in the management of pruritus in chronic spontaneous urticaria in the pediatric population

被引：0
|
作者：
Mitra, B. [1 ]
机构：
[1] Base Hosp Delhi Cantt, Dept Pediat, New Delhi, India
来源：
EXPERIMENTAL DERMATOLOGY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
6
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [21] MONTELUKAST IN THE TREATMENT OF CHRONIC URTICARIA: A RANDOMIZED DOUBLE BLIND, PLACEBO-CONTROLLED STUDY
    Agcaoili, M. L.
    Sumpaico, M. W.
    Aleta, L. A.
    Recto, M. P.
    Abong, J. M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : A17 - A17
  • [22] Efficacy and Safety of Omalizumab in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
    Casale, Thomas
    Maurer, Marcus
    Hsieh, Hsin-Ju
    Canvin, Janice
    Saini, Sarbjit S.
    Grattan, Clive
    Gimenez-Arnau, Ana
    Kaplan, Allen P.
    Rosen, Karin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB327 - AB327
  • [23] Randomized, Placebo-Controlled, Double-Blind Study of Ropinirole in Chronic Stroke
    Cramer, Steven C.
    Dobkin, Bruce H.
    Noser, Elizabeth A.
    Rodriguez, Rachelle W.
    Enney, Lori A.
    STROKE, 2009, 40 (09) : 3034 - 3038
  • [24] Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) treated with omalizumab: results of three randomized, double-blind, placebo-controlled clinical trials
    Spector, S.
    Antonova, E.
    Trzaskoma, B.
    Omachi, T. A.
    Zazzali, J. L.
    ALLERGY, 2015, 70 : 154 - 155
  • [25] IMPROVEMENT OF SLEEP IN PATIENTS WITH CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA (CIU/CSU) TREATED WITH OMALIZUMAB: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL (GLACIAL)
    Antonova, J.
    Raimundo, K.
    Trzaskoma, B.
    Solari, P.
    Omachi, T.
    Zazzali, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A114 - A115
  • [26] OXATOMIDE IN THE TREATMENT OF CHRONIC URTICARIA - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    PEREMANS, W
    MERTENS, RLJ
    MORIAS, J
    CAMPAERT, H
    DERMATOLOGICA, 1981, 162 (01): : 42 - 50
  • [27] Omalizumab normalizes levels of high affinity immunoglobulin E receptor-positive skin cells in patients with chronic spontaneous urticaria: a randomized, double-blind, placebo-controlled study
    Metz, M.
    Staubach, P.
    Bauer, A.
    Brehler, R.
    Gericke, J.
    Ashton-Chess, J.
    Jarvis, P.
    Canvin, J.
    Erpenbeck, V. J.
    Maurer, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S30 - S30
  • [28] EFFICACY OF OMALIZUMAB, AN ANTI-IGE RECOMBINANT, HUMANIZED, MONOCLONAL ANTIBODY, FOR THE TREATMENT OF SEVERE CHRONIC IDIOPATHIC URTICARIA PATIENTS NOT CONTROLLED ON ORAL ANTIHISTAMINES
    Nsouli, S. M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A117 - A117
  • [29] DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF TERFENADINE AND HYDROXYZINE IN PATIENTS WITH CHRONIC IDIOPATHIC URTICARIA
    BOGGS, PB
    ELLIS, CN
    GROSSMAN, J
    WASHBURNE, WF
    GUPTA, AK
    BALL, R
    SHULAN, D
    ANNALS OF ALLERGY, 1989, 63 (06): : 616 - 620
  • [30] Gabapentin in patients with the pruritus of cholestasis: A double-blind, randomized, placebo-controlled trial
    Bergasa, Nora V.
    McGee, Monnie
    Ginsburg, Iona H.
    Engler, Danielle
    HEPATOLOGY, 2006, 44 (05) : 1317 - 1323
12345